# Cell-Free DNA Chromatin Immunoprecipitation (ChIP) for Diagnosing Cancer

> **NCT06148298** · — · RECRUITING · sponsor: **University of Central Florida** · enrollment: 24 (estimated)

## Conditions studied

- Cancer of Pancreas

## Interventions

- **OTHER:** Non-Human Subject Research study.

## Key facts

- **NCT ID:** NCT06148298
- **Lead sponsor:** University of Central Florida
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2023-05-24
- **Primary completion:** 2025-05
- **Final completion:** 2025-05
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2024-12-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06148298

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06148298, "Cell-Free DNA Chromatin Immunoprecipitation (ChIP) for Diagnosing Cancer". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT06148298. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*